Zi-chen Zhang

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma.

Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma.

Journal: Nature
Published: July 30, 2025

Performance of common genetic variants in risk prediction for colorectal cancer in Chinese: A two-stage and multicenter study.

Performance of common genetic variants in risk prediction for colorectal cancer in Chinese: A two-stage and multicenter study.

Journal: Genomics
Published: July 12, 2020

The Percentage of Anaplastic Lymphoma Kinase-Positive Tumor Cells Has Clinical Implications for Patients with Non-Small Cell Lung Cancer.

The Percentage of Anaplastic Lymphoma Kinase-Positive Tumor Cells Has Clinical Implications for Patients with Non-Small Cell Lung Cancer.

Journal: Genetic testing and molecular biomarkers
Published: August 03, 2019

Prognosis and staging of parotid lymph node metastasis in nasopharyngeal carcinoma: An analysis in 10,126 patients.

Prognosis and staging of parotid lymph node metastasis in nasopharyngeal carcinoma: An analysis in 10,126 patients.

Journal: Oral oncology
Published: January 29, 2019

Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.

Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.

Journal: Cancer
Published: April 29, 2018

Hypermethylation of APC2 Is a Predictive Epigenetic Biomarker for Chinese Colorectal Cancer.

Hypermethylation of APC2 Is a Predictive Epigenetic Biomarker for Chinese Colorectal Cancer.

Journal: Disease markers
Published: March 30, 2018

Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma.

Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma.

Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: May 15, 2016

Comparison of KRAS mutation status between primary tumor and metastasis in Chinese colorectal cancer patients.

Comparison of KRAS mutation status between primary tumor and metastasis in Chinese colorectal cancer patients.

Journal: Medical oncology (Northwood, London, England)
Published: February 25, 2016

Mutation profiling in chinese patients with metastatic colorectal cancer and its correlation with clinicopathological features and anti-EGFR treatment response.

Mutation profiling in chinese patients with metastatic colorectal cancer and its correlation with clinicopathological features and anti-EGFR treatment response.

Journal: Oncotarget
Published: February 17, 2016

Serum microRNA profiles as prognostic biomarkers for HBV-positive hepatocellular carcinoma.

Serum microRNA profiles as prognostic biomarkers for HBV-positive hepatocellular carcinoma.

Journal: Oncotarget
Published: January 28, 2016

Concurrent oncogene mutation profile in Chinese patients with stage Ib lung adenocarcinoma.

Concurrent oncogene mutation profile in Chinese patients with stage Ib lung adenocarcinoma.

Journal: Medicine
Published: December 30, 2014

The Frequency and Clinical Implication of ROS1 and RET Rearrangements in Resected Stage IIIA-N2 Non-Small Cell Lung Cancer Patients.

The Frequency and Clinical Implication of ROS1 and RET Rearrangements in Resected Stage IIIA-N2 Non-Small Cell Lung Cancer Patients.

Journal: PloS one
Published: October 26, 2014
Showing 1-12 of 15

Last Updated: 09/26/2026